Remove Heart Failure Remove Heart Valves Remove Quality of Life
article thumbnail

AHA Raises Awareness on HVD

DAIC

22, 2025More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the American Heart Association 2025 Heart Disease and Stroke Statistical Update. This year on Heart Valve Disease Awareness Day (Feb. tim.hodson Tue, 03/04/2025 - 14:11 Feb.

article thumbnail

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

DAIC

Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected.

Tricuspid 105
article thumbnail

New Treatment Options Available for Patients with Tricuspid Valve Disease

DAIC

Raj Makkar, MD: Tricuspid regurgitation is a condition where the tricuspid valve fails to close properly, allowing blood to flow backward into the right atrium. How has treatment for tricuspid valve disease evolved? We prioritize improving quality of life, particularly for patients experiencing severe fatigue and breathlessness.

article thumbnail

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

The panel's vote will be considered by the FDA when making a decision regarding the approval of TriClip, a first-of-its-kind minimally invasive device specifically designed to treat the difficult-to-access tricuspid valve. chief medical officer and divisional vice president of medical affairs of Abbott's structural heart business.

Tricuspid 102
article thumbnail

Taskforce Develops New Standards to Monitor Adults with Heart Valve Disease

DAIC

Highlights include: Due to the aging population and improvement in diagnostic strategies, the prevalence of heart valve disease is expected to double by 2040 and triple by 2060.As As a result, it is estimated that the number of patients requiring heart valve interventions will increase significantly in the coming decades.

article thumbnail

Cardiology Team Performs Novel Heart Artery Repair with Newly Approved Device

DAIC

Image courtesy of UC Davis Health milla1cf Tue, 04/09/2024 - 16:47 April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with tricuspid regurgitation , or a leaky heart valve, by using a groundbreaking catheter. Food and Drug Administration (FDA) last week.

Tricuspid 111
article thumbnail

The Texas Heart Institute Collaborates on Multi-institutional DOD Grant to Develop Novel Left Ventricular Assist Device

DAIC

suffer from heart failure , and there are approximately 400,000 heart-failure-related deaths in this country each year. Patients with heart failure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden.